Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Transfusion. 2016 Jan 26;56(6 Pt 2):1588–1597. doi: 10.1111/trf.13469

TABLE 1.

Reasons for deenrollment by group assignment

Group assignment Deenrollment type
Passive withdrawal
Protocol* Adverse event Medical Permanent deferral Active withdrawal Total Known Lost to follow-up
Iron status letter 5 N/A 1 0 3 9 5 27
No information letter 2 N/A 5 1 2 10 3 21
38 mg of iron 1 16 6 0 23 46 1 16
19 mg of iron 9 12 6 0 27 54 2 20
Placebo 5 11 14 0 34 64 2 19
Total 22 39 32 1 89 183 13 103
*

Subjects removed from study per protocol, e.g., determined to be taking vitamins with iron before enrollment or had ferritin level exceeding 300 ng/mL.

Includes those not wanting to take pills, physician recommended study withdrawal, or medical or surgical reasons unrelated to study.

Known passive refusals are those who reported moving outside the study area.